Course Description
The content in this webinar assists with building and expanding LAI clinics by outlining policies and procedures for administering LAIs; logistic considerations related to the location, room, and supplies; billing challenges and opportunities; marketing tips; and patient communication techniques.
Learning Objectives
- Outline policies, procedures, and workflow processes for administering long-acting injectables (LAIs) in a practice setting.
- Describe opportunities and challenges related to billing for LAI services.
- Discuss location, room, and supply needs for administering LAIs in a practice setting.
- Review options for marketing the LAI service to psychiatric providers.
Target Audience
We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.
Faculty
View biographical information
Jerry McKee, PharmD, MS, BCPP, FAAPP
CEO and Chief Clinical Officer- Psychopharm Solutions LLC
Dr. Jerry McKee is a board-certified psychiatric pharmacy specialist with over 43 years in leadership roles in public mental health inpatient psychiatry, residential IDD services, academia, and behavioral health managed care in Texas, Tennessee and North Carolina. Dr. McKee is Board Certified in Psychiatric and Neurologic Pharmacy, having received his undergraduate and graduate pharmacy training at the University of North Carolina, and currently serves as CEO and Chief Clinical Officer for Psychopharm Solutions LLC, a behavioral health pharmacy consultant management firm serving the southeast, based in Morganton, North Carolina. He is past president of the American Association of Psychiatric Pharmacists and former two-term member of the Board of Pharmacy Specialties Executive Council. Dr. McKee has published and presented frequently on topics related to his field and has frequently provided expert testimony related to psychopharmacology in civil lawsuits. Dr. McKee is currently serving as the project manager for a North Carolina Medicaid behavioral health whole person care plan grant. This initiative aims to develop, implement, and evaluate scalable, reasonable, and fair payment models for pharmacy-based services. The project specifically targets improving the physical and behavioral health outcomes of plan members—individuals diagnosed with serious mental illness and substance use disorders. The four key services include LAI Administration and Patient Management, Tobacco Cessation Counseling and Prescribing, Adherence Support, and Point of Care Testing.
Dr. McKee is a certified adult Mental Health First Aid instructor and is on a mission to
reduce stigma regarding mental illness in the pharmacy and primary care communities.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Complete the pre-test (if applicable) before starting the activity.
- Review the full content of the activity and reflect upon its teachings.
- Complete the post-test at the end of the activity no later than the closing activity date.
- Complete the evaluation at the end of the activity.
- If necessary, complete the post-test retest no later than the closing activity date.
- Receive a passing grade (70%).
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 06/01/2026-06/01/2029
ACPE Contact Hours: 1
ACPE Number: 0284-0000-26-046-H01-P (Knowledge)
 | The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
View Faculty, Program Planning Committee/Reviewers Disclosures of Interest
Faculty: Jerry McKee, PharmD, MS, BCPP, FAAPP has nothing to disclose
Planning Committee/Peer Reviewers:
- Andria F. Church, PharmD, BCPP has nothing to disclose
- Beth DeJongh, PharmD, FAAPP, BCPP, BCPS has nothing to disclose
*All identified conflicts of interest have been mitigated.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Copyright Statement, Terms of Use, and Policies
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
This activity is supported by an educational grant from Johnson & Johnson.